Humacyte Inc at H.C. Wainwright BioConnect Investor Conference Transcript
Good afternoon, everyone, and welcome to the HC Wainwright BioConnect Investor Conference. My name is Louis Susser, and I'm on the corporate access team at HC Wainwright. I'm pleased to introduce you to Laura Niklason, who is the Founder and CEO of Humacyte.
Thank you so much. It's great to be here. We're having a terrific time at this meeting and having a lot of great one-on-one interactions.
So I'm here to tell you about Humacyte at a very high level. And of course, anybody who wants to follow up with myself or with Dale Sander, our CFO, who's also here with me today, we're happy to do that.
So Humacyte is a publicly traded company. This is just our forward-looking statements.
So Humacyte is really a technology platform. We are the only company on the planet that has developed methods to engineer human spare parts, replacement human tissues, and we make these tissues now at commercial scale. And the beauty of these tissues is that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
